{"id":"intranasal-midazolam","safety":{"commonSideEffects":[{"rate":null,"effect":"Sedation"},{"rate":null,"effect":"Drowsiness"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nasal irritation"},{"rate":null,"effect":"Respiratory depression"}]},"_chembl":{"chemblId":"CHEMBL655","moleculeType":"Small molecule","molecularWeight":"325.77"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Midazolam binds to GABA-A receptors and potentiates the effect of the inhibitory neurotransmitter GABA, leading to increased chloride ion influx and neuronal hyperpolarization. This results in central nervous system depression characterized by sedation, anxiolysis, and muscle relaxation. The intranasal formulation provides rapid onset of action suitable for acute anxiety and seizure management.","oneSentence":"Midazolam is a benzodiazepine that enhances the inhibitory effects of GABA at GABA-A receptors in the central nervous system, producing sedation and anxiolysis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:49:37.412Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute seizure management"},{"name":"Acute anxiety and agitation"},{"name":"Procedural sedation"}]},"trialDetails":[{"nctId":"NCT07498387","phase":"NA","title":"Management of Catatonic Features in Adolescents With Profound Autism","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tanta University","startDate":"2026-01-01","conditions":"Autism Spectrum Disorder, Catatonia","enrollment":30},{"nctId":"NCT07227454","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2026-01-08","conditions":"Depressive Disorder, Major","enrollment":258},{"nctId":"NCT06417125","phase":"PHASE4","title":"Intranasal Dexmedetomidine Versus Oral Midazolam Premedication for Postoperative Negative Behavior Changes in Children","status":"COMPLETED","sponsor":"Fujian Provincial Hospital","startDate":"2024-05-22","conditions":"Behavior Problem","enrollment":324},{"nctId":"NCT05121324","phase":"PHASE3","title":"Pediatric Dose Optimization for Seizures in Emergency Medical Services","status":"RECRUITING","sponsor":"Stanford University","startDate":"2022-08-08","conditions":"Seizures","enrollment":6700},{"nctId":"NCT07166666","phase":"NA","title":"Study Comparing Atomizerd Midazolam & Fentanyl and Dexmedomidine for Procedural Sedation in Adult and Pediatric Patient (2 to 60 Years Old)","status":"NOT_YET_RECRUITING","sponsor":"Oman Medical Speciality Board","startDate":"2025-09-01","conditions":"Sedation, Analgesia Assessment","enrollment":128},{"nctId":"NCT05057689","phase":"PHASE2","title":"Safety & Efficacy of Intranasal Dexmedetomidine, Fentanyl & Midazolam in the Pediatric Emergency Room","status":"WITHDRAWN","sponsor":"Nationwide Children's Hospital","startDate":"2025-09","conditions":"Acute Stress Disorder, Anxiety, Pain","enrollment":""},{"nctId":"NCT06330584","phase":"PHASE2","title":"Administration of Intranasal Midazolam for Anxiety in Palliative Care","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2024-12-20","conditions":"Anxiety, Acute Anxiety, Palliative Care","enrollment":36},{"nctId":"NCT04586504","phase":"PHASE1, PHASE2","title":"Dose-Finding Study of Intranasal Midazolam for Procedural Sedation in Children","status":"COMPLETED","sponsor":"Columbia University","startDate":"2021-09-08","conditions":"Procedural Anxiety","enrollment":101},{"nctId":"NCT07072117","phase":"NA","title":"Intranasal Dexmedetomidine, Ketamine or Midazolam for Anxiety and Respiratory Complications in Children","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2023-02-20","conditions":"Adenotonsillectomy","enrollment":148},{"nctId":"NCT07045597","phase":"NA","title":"Intranasal Midazolam for Preanasthetic Sedation for Preschool Children Undergoing Adenotonsillectomy.","status":"RECRUITING","sponsor":"Sohag University","startDate":"2025-03-13","conditions":"Adenotonsillar Hypertrophy","enrollment":100},{"nctId":"NCT07021755","phase":"NA","title":"Use Of Midazolam In Premedication Of Pediatric Patients","status":"COMPLETED","sponsor":"Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey","startDate":"2009-06-01","conditions":"Separation, Family, Separation Anxiety","enrollment":60},{"nctId":"NCT07013955","phase":"PHASE3","title":"Comparative Study Between the Effect of Dexmedetomidine ,Midazolam or Bupivacaine Packing During FESS on Surgical Field Visualization","status":"ENROLLING_BY_INVITATION","sponsor":"Minia University","startDate":"2025-04-01","conditions":"Surgical Hemostasis","enrollment":144},{"nctId":"NCT06979791","phase":"PHASE2","title":"Comparing Two Doses of Midazolam With Added Dexmedetomidine for Kids Before Surgery","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-06-01","conditions":"Preoperative Anxiety Experienced by the Pediatric Patient, Preoperative Anxiety","enrollment":60},{"nctId":"NCT05383495","phase":"PHASE3","title":"Anxiolysis for Laceration Repair in Children","status":"RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2023-12-19","conditions":"Laceration of Skin, Distress, Emotional","enrollment":300},{"nctId":"NCT03185819","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-10-05","conditions":"Depressive Disorder, Major","enrollment":147},{"nctId":"NCT06889376","phase":"PHASE1","title":"Use of Intranasal Midazolam to Reduce Stress and Procedural Pain in Premature Infants During Routine ROP Examination.","status":"NOT_YET_RECRUITING","sponsor":"Polish Mother Memorial Hospital Research Institute","startDate":"2025-03-24","conditions":"Drug Safety","enrollment":40},{"nctId":"NCT02568176","phase":"PHASE1","title":"Pharmacokinetic Study of Intranasal Esketamine and Its Effects on the Pharmacokinetics of Orally-Administered Midazolam and Bupropion in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-10","conditions":"Healthy","enrollment":71},{"nctId":"NCT02168439","phase":"PHASE4","title":"Intranasal Dexmedetomidine vs Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2014-06","conditions":"Laceration, Anxiety","enrollment":40},{"nctId":"NCT06670846","phase":"NA","title":"Management of Preoperative Anxiety in Children: Could a Lollipop Be the Solution?","status":"RECRUITING","sponsor":"Tunis University","startDate":"2024-01-02","conditions":"Anxiety, Preoperative","enrollment":63},{"nctId":"NCT06122948","phase":"PHASE3","title":"Effect of Intranasal Midazolam Versus Ketamine Midazolam Combination as a Premedication on the Occurrence of Postoperative Respiratory Adverse Events","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2023-11-04","conditions":"Tonsillectomy, Adenoidectomy, Drug-Related Side Effects and Adverse Reaction","enrollment":200},{"nctId":"NCT06194747","phase":"NA","title":"Improving Status Epilepticus Treatment Times","status":"RECRUITING","sponsor":"Nationwide Children's Hospital","startDate":"2024-02-01","conditions":"Status Epilepticus","enrollment":450},{"nctId":"NCT05934669","phase":"PHASE4","title":"IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED","status":"RECRUITING","sponsor":"University of Oklahoma","startDate":"2023-11-14","conditions":"Laceration of Skin, Anxiety, Discharge Time","enrollment":90},{"nctId":"NCT05324852","phase":"PHASE3","title":"AGItated Patients Management: intraNASAL Midazolam vs Intramuscular Loxapine","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-04-09","conditions":"Emergence Delirium","enrollment":1},{"nctId":"NCT06389318","phase":"NA","title":"Buccal Midazolam Versus Intranasal Dexmedetomidine Plus Oral Chloral Hydrate in Inguinal Hernia Repair","status":"COMPLETED","sponsor":"Benha University","startDate":"2023-03-26","conditions":"Inguinal Hernia Repair","enrollment":80},{"nctId":"NCT05670509","phase":"PHASE4","title":"Intranasal vs Buccal vs Intramuscular Midazolam for the Home and Emergency Treatment of Acute Seizures","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2019-01-19","conditions":"Convulsions","enrollment":305},{"nctId":"NCT06181682","phase":"PHASE4","title":"Intranasal Dexmedetomidine Versus Intranasal Midazolam as a Premedication in Pediatrics Undergoing Upper GI Endoscopy","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2024-01","conditions":"Anesthesia","enrollment":70},{"nctId":"NCT04356638","phase":"PHASE3","title":"a Phase III Trial of Safety and Efficacy of Premedication With Dexmedetomidine and Midazolam in Pediatric Patients","status":"UNKNOWN","sponsor":"King Faisal Specialist Hospital & Research Center","startDate":"2021-10-17","conditions":"Anxiety State, Perioperative/Postoperative Complications","enrollment":80},{"nctId":"NCT05883150","phase":"PHASE2, PHASE3","title":"Intranasal Versus Nebulized Midazolam in Behaviuor Modification of Preschool Children Undergoing Dental Treatment","status":"COMPLETED","sponsor":"Nourhan M.Aly","startDate":"2022-11-10","conditions":"Dental Sedation","enrollment":68},{"nctId":"NCT05925283","phase":"PHASE4","title":"Clinical Study of Oral Midazolam Combined With Esketamine Administered Intranasally for Pediatric Preoperative Sedation","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Wenzhou Medical University","startDate":"2023-06-30","conditions":"Anxiety","enrollment":126},{"nctId":"NCT03043430","phase":"PHASE4","title":"Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients","status":"TERMINATED","sponsor":"Brooke Army Medical Center","startDate":"2016-05","conditions":"Anxiety, Pediatric ALL, Procedural Anxiety","enrollment":10},{"nctId":"NCT04652661","phase":"PHASE4","title":"Intranasal Dexmedetomidine Versus Intranasal Midazolam for MRI In Pediatrics","status":"COMPLETED","sponsor":"Tanta University","startDate":"2020-12-10","conditions":"Dexmedetomidine, Midazolam, MRI","enrollment":60},{"nctId":"NCT04571879","phase":"PHASE3","title":"Nebulized Lidocaine and Intranasal Midazolam for NGT Insertion in Children","status":"UNKNOWN","sponsor":"Hamad Medical Corporation","startDate":"2021-08-25","conditions":"Procedural Anxiety, Procedural Pain","enrollment":48},{"nctId":"NCT04509414","phase":"PHASE4","title":"Intranasal Dexmedetomidine for Deep-sedated Pediatric Dental Patients","status":"COMPLETED","sponsor":"Peking University","startDate":"2020-04-10","conditions":"Deep Sedation, Dexmedetomidine","enrollment":100},{"nctId":"NCT01529034","phase":"PHASE3","title":"Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters","status":"TERMINATED","sponsor":"UCB Biopharma S.P.R.L.","startDate":"2012-07","conditions":"Epilepsy","enrollment":175},{"nctId":"NCT03399838","phase":"PHASE4","title":"Comparing in Dexmedetomidine With po/pr Midazolam for Procedural Sedation in the Pediatric Emergency Department","status":"WITHDRAWN","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2023-08","conditions":"Procedural Anxiety, Emergencies","enrollment":""},{"nctId":"NCT04266340","phase":"NA","title":"Different Premedication in Pediatric Patients","status":"COMPLETED","sponsor":"Eye & ENT Hospital of Fudan University","startDate":"2020-12-13","conditions":"Agitation","enrollment":320},{"nctId":"NCT03085563","phase":"PHASE4","title":"A Comparison of Intranasal Midazolam and Nitrous Oxide (N2O) Minimal Sedation for Minor Procedures in a Pediatric Emergency Department","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2017-05-24","conditions":"Conscious Sedation, Simple Lacerations Less Than 4 cm, Lumbar Punctures","enrollment":63},{"nctId":"NCT04924621","phase":"NA","title":"Sedation Compaired With Anesthesia With THRIVE in Endotracheal Intubation With Difficult Airways","status":"UNKNOWN","sponsor":"Peking University","startDate":"2021-06-10","conditions":"Sedative, Hypnotic, or Anxiolytic Withdrawal, Airway Control","enrollment":42},{"nctId":"NCT05192629","phase":"PHASE3","title":"Intranasal Dexmedetomidine Versus Oral Midazolam as Premedication for Propofol Sedation in Pediatric Patients Undergoing Magnetic Resonance Imaging","status":"UNKNOWN","sponsor":"Brugmann University Hospital","startDate":"2022-03-09","conditions":"MRI, Pediatric Sedation, Midazolam","enrollment":250},{"nctId":"NCT02356705","phase":"PHASE4","title":"Intranasal Midazolam in Children as a Pre-Operative Sedative - Part 2","status":"COMPLETED","sponsor":"Jennifer Victory, RN, CCRC","startDate":"2015-01","conditions":"Sedation","enrollment":42},{"nctId":"NCT03528512","phase":"PHASE4","title":"IN Ketamine vs IN Midazolam and Fentanyl for Laceration Repair","status":"TERMINATED","sponsor":"Corewell Health East","startDate":"2018-09-04","conditions":"Laceration of Skin","enrollment":5},{"nctId":"NCT04704622","phase":"PHASE2, PHASE3","title":"Comparison Between Dexmeditomidine, Midazolam and Ketamine as a Sedative to Help Cannula Insertion in Pediatric Patient","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2021-01-01","conditions":"Cannula Site Pain","enrollment":150},{"nctId":"NCT04885075","phase":"PHASE4","title":"Comparing the Efficacy of Intranasal Midazolam Versus Intravenous Diazepam for Control of Seizures in Children","status":"UNKNOWN","sponsor":"Shaheed Zulfiqar Ali Bhutto Medical University","startDate":"2021-05-30","conditions":"Seizures","enrollment":60},{"nctId":"NCT04816344","phase":"","title":"Emergence Delirium in Children for Magnetic Resonance Imaging","status":"COMPLETED","sponsor":"Turkiye Yuksek Ihtisas Education and Research Hospital","startDate":"2018-07-01","conditions":"Delirium, Pediatric Disorder, Anesthesia","enrollment":140},{"nctId":"NCT04621110","phase":"PHASE3","title":"Intranasal Versus Intravenous Drug in Painful Procedure for Outpatient Oncologic Participants","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2021-06-01","conditions":"Pediatric Cancer, Analgesia, Procedural Pain","enrollment":60},{"nctId":"NCT03597477","phase":"","title":"Procedure Sedation With Dexmedetomidine in Children With Autism Spectrum Disorders During Magnetic Resonance Imaging","status":"COMPLETED","sponsor":"Guangzhou Women and Children's Medical Center","startDate":"2018-07-16","conditions":"Autism Spectrum Disorder","enrollment":136},{"nctId":"NCT04745260","phase":"NA","title":"Intranasal Fentanyl in Combination With Midazolam Versus Midazolam Alone for Pediatric Facial Laceration Repair","status":"UNKNOWN","sponsor":"University of Texas at Austin","startDate":"2021-03-01","conditions":"Facial Laceration, Anxiety","enrollment":100},{"nctId":"NCT04608734","phase":"PHASE2","title":"Buccal Versus Intranasal Route of Administration of Midazolam Spray in Behavior Management of Pre-School Patients","status":"COMPLETED","sponsor":"Nourhan M.Aly","startDate":"2015-06-10","conditions":"Dental Anxiety","enrollment":36},{"nctId":"NCT04263844","phase":"PHASE4","title":"Intranasal Dexmedetomidine Versus Intranasal Midazolam for Emergence Delirium Prevention","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2019-01-10","conditions":"Emergence Delirium","enrollment":66},{"nctId":"NCT04135014","phase":"PHASE4","title":"Combination With Intranasal Dexmedetomidine and Oral Midazolam for Premedication in Pediatric Patients","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Wenzhou Medical University","startDate":"2019-10-25","conditions":"Anxiety","enrollment":138},{"nctId":"NCT02161185","phase":"PHASE3","title":"A Long-term Safety and Tolerability Study of USL261 in Patients With Seizure Clusters","status":"TERMINATED","sponsor":"UCB Biopharma S.P.R.L.","startDate":"2014-05","conditions":"Epilepsy","enrollment":7},{"nctId":"NCT01999777","phase":"PHASE3","title":"Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMU","status":"COMPLETED","sponsor":"UCB Biopharma S.P.R.L.","startDate":"2013-11","conditions":"Epilepsy","enrollment":62},{"nctId":"NCT01390220","phase":"PHASE3","title":"Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters","status":"TERMINATED","sponsor":"UCB Biopharma S.P.R.L.","startDate":"2011-06","conditions":"Epilepsy","enrollment":292},{"nctId":"NCT03054844","phase":"PHASE2","title":"PREMIX vs PREMED Intranasal Lidocaine and Midazolam","status":"COMPLETED","sponsor":"Columbia University","startDate":"2017-04-03","conditions":"Pain","enrollment":55},{"nctId":"NCT04083105","phase":"PHASE4","title":"Nitrous Oxide Prior to Intranasal Midazolam for Moderate Dental Sedation in Pediatric Patients","status":"UNKNOWN","sponsor":"Children's Hospital Colorado","startDate":"2019-07-12","conditions":"Dental Anxiety, Pain","enrollment":150},{"nctId":"NCT01948908","phase":"PHASE2","title":"Volumes of Administration for Intranasal Midazolam","status":"COMPLETED","sponsor":"Columbia University","startDate":"2013-06","conditions":"Children Requiring Sedation to Facilitate Laceration Repair","enrollment":99},{"nctId":"NCT03860831","phase":"PHASE1","title":"Intranasal Ketamine and Midazolam Mixture for Procedural Sedation in Children With Mental Disabilities:","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2019-03-06","conditions":"Procedural Sedation","enrollment":40},{"nctId":"NCT00675909","phase":"NA","title":"Improving Sedation of Children Undergoing Procedures in the Emergency Department","status":"COMPLETED","sponsor":"Seattle Children's Hospital","startDate":"2006-11","conditions":"Anxiety","enrollment":180},{"nctId":"NCT03725995","phase":"PHASE2, PHASE3","title":"Using Intranasal Midazolam (INM) and Lidocaine for Uncooperative Children","status":"COMPLETED","sponsor":"Tishreen University","startDate":"2017-06-01","conditions":"Burning Nose","enrollment":63},{"nctId":"NCT03394430","phase":"PHASE4","title":"Comparison of Midazolam or Dexmedetomidine on Epileptiform EEG During Sevoflurane Mask Induction","status":"UNKNOWN","sponsor":"Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University","startDate":"2018-10-01","conditions":"Inhalation Anesthesia","enrollment":45},{"nctId":"NCT03635398","phase":"NA","title":"Intranasal Midazolam for Pediatric Pre-procedural Sedation and Pre-procedural Anti-anxiety Using sipNose Device - a Randomized Controlled Study","status":"UNKNOWN","sponsor":"Rabin Medical Center","startDate":"2018-08","conditions":"Procedural Sedation, Intra-nasal Delevery Device","enrollment":300},{"nctId":"NCT03171740","phase":"PHASE3","title":"Premedication With Intranasal Dexmedetomidine or Midazolam for Prevention of Emergence Agitation in Children","status":"COMPLETED","sponsor":"Brasilia University Hospital","startDate":"2017-06-01","conditions":"Emergence Delirium","enrollment":22},{"nctId":"NCT02447289","phase":"PHASE4","title":"Midazolam and Ketamine Effect Administered Through the Nose for Sedation of Children for Dental Treatment","status":"COMPLETED","sponsor":"Universidade Federal de Goias","startDate":"2015-05-21","conditions":"Child Behavior, Dental Caries","enrollment":84},{"nctId":"NCT02250703","phase":"PHASE3","title":"Intranasal Dexmedetomidine Premedication in Children","status":"COMPLETED","sponsor":"University of Mississippi Medical Center","startDate":"2014-09","conditions":"Preoperative Sedation","enrollment":75},{"nctId":"NCT02206776","phase":"PHASE2","title":"Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD","status":"TERMINATED","sponsor":"New York State Psychiatric Institute","startDate":"2014-09","conditions":"Obsessive-Compulsive Disorder","enrollment":2},{"nctId":"NCT02635282","phase":"PHASE4","title":"IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D","status":"COMPLETED","sponsor":"University of Tennessee","startDate":"2016-08","conditions":"Abscess, Pain","enrollment":19},{"nctId":"NCT02396537","phase":"NA","title":"Efficacy of Topical Lidocaine to Decrease Discomfort With Intranasal Midazolam Administration","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2014-01","conditions":"Pain","enrollment":77},{"nctId":"NCT02985697","phase":"PHASE4","title":"Safety and Efficacy of Intranasal Dexmedetomidine","status":"UNKNOWN","sponsor":"Bon Secours Pediatric Dental Associates","startDate":"2017-01","conditions":"Safety and Efficacy of Intranasal Dexmedetomidine","enrollment":100},{"nctId":"NCT02618772","phase":"PHASE4","title":"Intranasal Midazolam for Treatment of Anxiety in Children Undergoing Suturing in the Pediatric Emergency Department","status":"COMPLETED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2010-01","conditions":"Anxiety, Lacerations","enrollment":79},{"nctId":"NCT02314546","phase":"PHASE4","title":"Intranasal Midazolam in Children as a Pre-Operative Sedative","status":"COMPLETED","sponsor":"Bassett Healthcare","startDate":"2011-12","conditions":"Sedation, Conscious","enrollment":15},{"nctId":"NCT02072083","phase":"PHASE4","title":"Intranasal Dexmedetomidine vs Midazolam-ketamine Combination for Premedication of Pediatric Patients","status":"COMPLETED","sponsor":"TC Erciyes University","startDate":"2014-02","conditions":"Premedication, Oculocardiac Reflex","enrollment":60},{"nctId":"NCT02408302","phase":"PHASE4","title":"Buccal Midazolam Versus Nasal or Oral Midazolam Sedation for Minor Invasive Procedures in Children","status":"UNKNOWN","sponsor":"Carmel Medical Center","startDate":"2015-04","conditions":"Dormicum, Conscious Sedation, Children","enrollment":90},{"nctId":"NCT02398136","phase":"PHASE2, PHASE3","title":"To Test the Potential Efficacy of Repeated Intranasal Administration of Ketamine as a Treatment for PTSD","status":"WITHDRAWN","sponsor":"Adriana Feder","startDate":"2014-12","conditions":"PTSD","enrollment":""},{"nctId":"NCT01316445","phase":"PHASE1","title":"Pharmacodynamics of Nasal and Buccal Midazolam Using EEG","status":"TERMINATED","sponsor":"Columbia University","startDate":"2011-07","conditions":"Epilepsy","enrollment":9},{"nctId":"NCT01895023","phase":"PHASE4","title":"Effects of Dexmedetomidine Premedication on Emergence Agitation After Strabismus Surgery in Children","status":"COMPLETED","sponsor":"Yao Yusheng","startDate":"2013-09","conditions":"Inhalational Anesthetics Adverse Reaction, Delirium on Emergence, Strabismus Following Ocular Surgery","enrollment":156},{"nctId":"NCT01517828","phase":"PHASE3","title":"Intranasal Midazolam Versus Intranasal Ketamine to Sedate Newborns for Intubation in Delivery Room","status":"UNKNOWN","sponsor":"University Hospital, Montpellier","startDate":"2012-01","conditions":"Respiratory Distress Syndrome, Prematurity of Fetus","enrollment":62},{"nctId":"NCT01188551","phase":"PHASE2, PHASE3","title":"Dexmedetomidine Versus Fentanyl Following Pressure Equalization Tube Placement","status":"COMPLETED","sponsor":"Nationwide Children's Hospital","startDate":"2011-01","conditions":"Chronic Otitis Media","enrollment":100},{"nctId":"NCT02022488","phase":"PHASE4","title":"Sevoflurane Induced Emergence Agitation","status":"COMPLETED","sponsor":"Yeditepe University Hospital","startDate":"2012-02","conditions":"Emergence Agitation","enrollment":78},{"nctId":"NCT01402596","phase":"PHASE2","title":"Evaluation of Pediatric Procedural Sedation With Rectal Chloral Hydrate or Intranasal Midazolam","status":"WITHDRAWN","sponsor":"University of Sao Paulo","startDate":"2011-08","conditions":"Traumatic Brain Injury, Computed Tomography, Procedural Sedation","enrollment":""},{"nctId":"NCT01275547","phase":"PHASE2, PHASE3","title":"The Analgesic Effect of Combined Treatment With Intranasal S-ketamine and Intranasal Midazolam","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2011-01","conditions":"Analgesia, Patient-controlled, Spinal Stenosis","enrollment":22},{"nctId":"NCT00326612","phase":"PHASE2","title":"Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures","status":"COMPLETED","sponsor":"University of Utah","startDate":"2006-06","conditions":"Seizures","enrollment":358}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":347,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["IN Midazolam","Dormire injectable solution, Cristalia, São Paulo, Brazil","Versed","IN midazolam","Intranasal Versed"],"phase":"marketed","status":"active","brandName":"Intranasal Midazolam","genericName":"Intranasal Midazolam","companyName":"Hamad Medical Corporation","companyId":"hamad-medical-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Midazolam is a benzodiazepine that enhances the inhibitory effects of GABA at GABA-A receptors in the central nervous system, producing sedation and anxiolysis. Used for Acute seizure management, Acute anxiety and agitation, Procedural sedation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}